Menopause Monitoring Profile
The Menopause Monitoring Profile is a blood test used to measure hormonal changes, metabolic health, and bone integrity during the menopausal transition. This provides understanding into a woman’s hormonal status and menopausal progression, symptom severity, and associated health risks—including cardiovascular disease and osteoporosis.
- Follicle Stimulating Hormone (FSH)
- Estradiol (E2)
- Calcium
- Phosphorus
- Lipid Profile.
Menopause Monitoring Profile helps evaluate hormonal changes and overall health status during the menopausal transition.
Who Should Take the Menopause Monitoring Profile?
1. Women ages 40+ experiencing:
- Irregular periods
- Hot flashes/night sweats
- Mood swings, fatigue, or sleep disturbances
- Vaginal dryness or low libido
2. Those considering or currently on HRT (to monitor therapy effectiveness)
3. Women with a family history of osteoporosis or heart disease
Components of the Menopause Monitoring Profile
- Follicle Stimulating Hormone (FSH):
- FSH levels increase as the ovaries become less responsive during menopause. Elevated FSH levels can indicate that a woman is approaching or has entered menopause.
- Estradiol (E2):
- Estradiol is a form of estrogen that decreases significantly during menopause. Low levels of E2 can contribute to symptoms such as hot flashes, mood changes, and vaginal dryness.
- Calcium:
- Monitoring calcium levels is important, as menopause can lead to decreased bone density, increasing the risk of osteoporosis.
- Phosphorus:
- Phosphorus levels are also assessed, as they play a role in bone health and metabolism.
- Lipid Profile:
- This includes measurements of cholesterol and triglycerides, which are important for assessing cardiovascular health. Menopause can affect lipid metabolism, potentially increasing the risk of heart disease.
Indications for Menopause Monitoring Profile
The Menopause Monitoring Profile is indicated for:
- Women experiencing symptoms of menopause, such as irregular periods, hot flashes, or mood swings.
- Assessing hormonal balance and determining the need for hormone replacement therapy (HRT).
- Monitoring overall health and risk factors associated with menopause, including bone density and cardiovascular health.
Menopause: Symptoms, Diagnosis & Treatment
| Category | Details | Notes |
|---|---|---|
| Common Symptoms | ||
| Vasomotor | Hot flashes, night sweats | Most disruptive symptom (affects 75% of women) |
| Reproductive | Vaginal dryness, painful sex, low libido | Caused by estrogen decline |
| Emotional | Mood swings, irritability, anxiety | Linked to hormonal fluctuations |
| Physical | Weight gain (abdomen), joint pain, thinning hair | Slowed metabolism post-menopause |
| Long-Term Risks | Osteoporosis, heart disease | Due to bone density loss + cholesterol changes |
| Diagnosis | ||
| Clinical | 12+ months without periods (age 45-55) | No tests needed if symptoms clear |
| Blood Tests | – FSH (>25 IU/L) – Estradiol (<30 pg/mL) – Thyroid (TSH) |
Rule out thyroid issues mimicking symptoms |
| Treatments | ||
| HRT | – Estrogen (patches/pills) – Progesterone (if uterus intact) |
Gold standard for flashes/vaginal dryness |
| Non-Hormonal Meds | – SSRIs (e.g., paroxetine) – Gabapentin (night sweats) |
For women who can’t take HRT |
| Vaginal Therapies | Moisturizers (e.g., Replens), local estrogen creams | Safe for long-term use |
| Lifestyle | – Strength training – Phytoestrogens (soy/flax) – Stress reduction |
Improves bone/heart health naturally |
Patient Preparation/Instructions
- Fasting: Required for accurate lipid results (8-12 hours; water allowed).
- Timing: For perimenopausal women, test on Day 3–5 of the menstrual cycle (if cycles are present).
- Medications: Consult your doctor about pausing HRT or supplements before testing.
- Sample Collection: A single blood draw (morning preferred for hormonal accuracy).
Turnaround Time for Menopause Monitoring Profile
Results from the Menopause Monitoring Profile generally take about 2 days to process.
Frequently Asked Questions
- Can this test diagnose menopause?
Yes—elevated FSH + low estradiol strongly suggest menopause, especially with symptoms. - How often should I repeat this test?
Annually during perimenopause; every 2–3 years postmenopause (or as advised). - Are there alternatives to blood tests?
Saliva or urine tests exist but are less standardized. Blood testing remains the gold standard. - Does insurance cover this panel?
Coverage varies; check with your provider. Self-pay options are affordable.
Order Menopause Monitoring Profile in kenya
Please click the ‘Order Test’ button and add Menopause Monitoring Profile to your cart.
You are welcome to visit our laboratory in Kilimani, Nairobi.
This will initiate the process for obtaining your test
